PEEL Therapeutics
Salt Lake City, US · Founded 2015 · Delaware corporation
Peel Therapeutics is a clinical-stage biotech company developing evolutionary-inspired medicines for cancer and immune diseases, including elephant p53 (EP53) nanoparticles. It uses its Darwin.AI platform, evolutionary biology, and comparative genomics to identify novel drug targets and molecules found in nature.
Founders & leadership
PEEL Therapeutics was founded in 2015 by Joshua Schiffman.
JS
Joshua SchiffmanFounder
AS
Avraham SchroederNamed on SEC filing
JL
James LevisonNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$9.3M disclosed across 1 round · 2017
▶$9.3MraisedFeb 2019 · 70 investors · BiotechnologyRule 506(c)
▶$9.3MraisedFeb 2019 · 70 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Avraham SchroederDirector
- Joshua SchiffmanExecutive Officer, Director
- James LevisonExecutive Officer
- Offering amount
- $10M
- Amount sold
- $9.3M
- First sale
- Oct 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with PEEL Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does PEEL Therapeutics do?
- Peel Therapeutics is a clinical-stage biotech company developing evolutionary-inspired medicines for cancer and immune diseases, including elephant p53 (EP53) nanoparticles. It uses its Darwin.AI platform, evolutionary biology, and comparative genomics to identify novel drug targets and molecules found in nature.
- Who founded PEEL Therapeutics?
- PEEL Therapeutics was founded by Joshua Schiffman in 2015.
- How much funding has PEEL Therapeutics raised?
- PEEL Therapeutics has disclosed $9.3M raised across 1 round.
- Where is PEEL Therapeutics headquartered?
- PEEL Therapeutics is headquartered in Salt Lake City, US.